OUR STRATEGY
We Recognize Change Early, and We Are Not Afraid to Change Course
Changing conditions are not obstacles but signals. We interpret them quickly, make informed decisions, and adjust our direction to stay relevant, and resilient.
CHIL Medical devices
A Commitment to Continuous Advancement
CHIL operates across the full development, industrialization, and commercialization lifecycle. We conduct advanced research and development to create new diagnostic products, and product-focused engineering to design and industrialize the manufacturing technologies required to produce them at scale. This integrated approach ensures that every product we develop is technically robust, manufacturable, and globally deployable.
Beyond development, we scale impact through structured global collaborations. We commercialize our products via international partnerships, transfer proprietary manufacturing technologies, and advance both innovative projects and the company itself through carefully selected investor collaborations. This strategy allows CHIL to expand efficiently while maintaining control over science, quality, and long-term value creation.
A Global Promise
At CHIL, we believe true success means never repeating ourselves. Our strategy is to continuously surpass our own achievements, to set new benchmarks that even our past successes cannot overshadow.
Rather than replicating existing products or systems, we focus on developing diagnostic technologies that make healthcare more accessible, faster, and more reliable. Our mission is to fill the critical gaps where diagnostics have lagged behind, creating smart and practical solutions that bring accuracy and speed together.
This is not just our strategy, it is our promise: because without the right and timely diagnosis, there can be no right treatment.
Not Replicating, Redefining
Rather than replicating existing products or systems, we focus on developing diagnostic technologies that make healthcare more accessible, faster, and more reliable. Our mission is to fill the critical gaps where diagnostics have lagged behind, creating smart and practical solutions that bring accuracy and speed together.
CHIL Medical devices
Expanding Our Strategic Horizons
As CHIL enters its next phase, we are opening selected dimensions of our business to external partners and investors. This includes equity participation at the company level, as well as structured engagement models around individual projects and diagnostic platforms. Each pathway is designed with clarity, governance, and long-term value creation in mind.
While the company remains anchored in its core scientific and operational principles, specific projects may be advanced through co-development, project-level equity, licensing, or strategic transfer structures. This flexible approach allows us to scale innovation efficiently, align expertise with opportunity, and create multiple, well-defined entry points for investment.
Empowering Local Production
We design projects that empower local production in every country, fostering a globally connected yet locally resilient diagnostic ecosystem.
By doing so, we aim to ensure faster and safer access to diagnostic testing worldwide, enabling earlier detection, saving more lives, and supporting the creation of healthier societies.
Mesaj Gönderin
Bize Ulaşın
Ekibimiz sizi dinlemeye, destek olmaya ve sizinle bağlantı kurmaya hazır.
Atatürk OSB, 10046. Sk. No:18, 35620
Çiğli /İzmir
Email: info@chil.com.tr
Telefon: (0232) 290 16 88